Product
1 mg NOC-110
1 clinical trial
1 indication
Indication
Refractory Chronic CoughClinical trial
A Phase 1, Two Part, Placebo-controlled, Single Dose Study in Healthy Volunteers and Multiple Dose Study in Patients With Refractory Chronic Cough to Assess the Safety, Tolerability, and PK of NTX-1175 Administered Via Nebulizer (NOC-100) and Dry Powder Inhaler (NOC-110)Status: Completed, Estimated PCD: 2022-10-25